These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
635 related items for PubMed ID: 15780468
21. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Pihlaja R, Koistinaho J, Malm T, Sikkilä H, Vainio S, Koistinaho M. Glia; 2008 Jan 15; 56(2):154-63. PubMed ID: 18004725 [Abstract] [Full Text] [Related]
22. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice. Dudal S, Krzywkowski P, Paquette J, Morissette C, Lacombe D, Tremblay P, Gervais F. Neurobiol Aging; 2004 Aug 15; 25(7):861-71. PubMed ID: 15212840 [Abstract] [Full Text] [Related]
23. The PDAPP mouse model of Alzheimer's disease: locus coeruleus neuronal shrinkage. German DC, Nelson O, Liang F, Liang CL, Games D. J Comp Neurol; 2005 Nov 28; 492(4):469-76. PubMed ID: 16228992 [Abstract] [Full Text] [Related]
24. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation. Guix FX, Ill-Raga G, Bravo R, Nakaya T, de Fabritiis G, Coma M, Miscione GP, Villà-Freixa J, Suzuki T, Fernàndez-Busquets X, Valverde MA, de Strooper B, Muñoz FJ. Brain; 2009 May 28; 132(Pt 5):1335-45. PubMed ID: 19251756 [Abstract] [Full Text] [Related]
25. Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice. Boncristiano S, Calhoun ME, Howard V, Bondolfi L, Kaeser SA, Wiederhold KH, Staufenbiel M, Jucker M. Neurobiol Aging; 2005 May 28; 26(5):607-13. PubMed ID: 15708435 [Abstract] [Full Text] [Related]
26. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress. Lee KW, Kim JB, Seo JS, Kim TK, Im JY, Baek IS, Kim KS, Lee JK, Han PL. J Neurochem; 2009 Jan 28; 108(1):165-75. PubMed ID: 19012747 [Abstract] [Full Text] [Related]
27. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease. Imbimbo BP, Giardino L, Sivilia S, Giuliani A, Gusciglio M, Pietrini V, Del Giudice E, D'Arrigo A, Leon A, Villetti G, Calzà L. J Alzheimers Dis; 2010 Jan 28; 20(1):159-73. PubMed ID: 20164581 [Abstract] [Full Text] [Related]
28. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease. Kuznetsova E, Schliebs R. Curr Pharm Des; 2013 Jan 28; 19(38):6749-65. PubMed ID: 23530514 [Abstract] [Full Text] [Related]
29. PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures. Brendza RP, O'Brien C, Simmons K, McKeel DW, Bales KR, Paul SM, Olney JW, Sanes JR, Holtzman DM. J Comp Neurol; 2003 Feb 17; 456(4):375-83. PubMed ID: 12532409 [Abstract] [Full Text] [Related]
30. Protective effect of stilbenes containing extract-fraction from Cajanus cajan L. on Abeta(25-35)-induced cognitive deficits in mice. Ruan CJ, Si JY, Zhang L, Chen DH, Du GH, Su L. Neurosci Lett; 2009 Dec 25; 467(2):159-63. PubMed ID: 19833171 [Abstract] [Full Text] [Related]
31. Absence of effect of chronic nicotine administration on amyloid beta peptide levels in transgenic mice overexpressing mutated human APP (Sw, Ind). Sabbagh MN, Walker DG, Reid RT, Stadnick T, Anand K, Lue LF. Neurosci Lett; 2008 Dec 26; 448(2):217-20. PubMed ID: 18926877 [Abstract] [Full Text] [Related]
32. Presynaptic serotonergic modulation of 5-HT and acetylcholine release in the hippocampus and the cortex of 5-HT1B-receptor knockout mice. Rutz S, Riegert C, Rothmaier AK, Buhot MC, Cassel JC, Jackisch R. Brain Res Bull; 2006 Jun 15; 70(1):81-93. PubMed ID: 16750486 [Abstract] [Full Text] [Related]
33. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease. Mohmmad Abdul H, Sultana R, Keller JN, St Clair DK, Markesbery WR, Butterfield DA. J Neurochem; 2006 Mar 15; 96(5):1322-35. PubMed ID: 16478525 [Abstract] [Full Text] [Related]
34. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. Christensen DZ, Kraus SL, Flohr A, Cotel MC, Wirths O, Bayer TA. Acta Neuropathol; 2008 Dec 15; 116(6):647-55. PubMed ID: 18974993 [Abstract] [Full Text] [Related]
35. Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human beta-amyloid. Craft JM, Watterson DM, Marks A, Van Eldik LJ. Glia; 2005 Aug 15; 51(3):209-16. PubMed ID: 15810011 [Abstract] [Full Text] [Related]
36. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody. Chauhan NB, Siegel GJ. J Neurosci Res; 2002 Jul 01; 69(1):10-23. PubMed ID: 12111811 [Abstract] [Full Text] [Related]
37. Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease. Noda-Saita K, Terai K, Iwai A, Tsukamoto M, Shitaka Y, Kawabata S, Okada M, Yamaguchi T. Acta Neuropathol; 2004 Nov 01; 108(5):435-42. PubMed ID: 15372280 [Abstract] [Full Text] [Related]
38. Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease. George AJ, Holsinger RM, McLean CA, Tan SS, Scott HS, Cardamone T, Cappai R, Masters CL, Li QX. Neurobiol Aging; 2006 Apr 01; 27(4):614-23. PubMed ID: 15941609 [Abstract] [Full Text] [Related]
39. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. Abdul HM, Calabrese V, Calvani M, Butterfield DA. J Neurosci Res; 2006 Aug 01; 84(2):398-408. PubMed ID: 16634066 [Abstract] [Full Text] [Related]
40. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease. He J, Luo H, Yan B, Yu Y, Wang H, Wei Z, Zhang Y, Xu H, Tempier A, Li X, Li XM. Neurobiol Aging; 2009 Aug 01; 30(8):1205-16. PubMed ID: 18079026 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]